Clinical Outcomes of Inhaled Amikacin in Ventilator-Associated Pneumonia: A group randomized controlled, add-on trial
Abstract
Background: Many clinical trials support the role of inhaled amikacin when combined with IV antibiotics in eradication of bacterial infections, reduce mortality and improve cure in ICU patients. Local contextual data is limited, leaving research gap.
Objective: To assess the effect of inhaled amikacin as an add-on adjunct to the intravenous antibiotics in ventilator- associated pneumonia ICU patients on clinical outcomes.
Methodology: This group randomized controlled add-on trial was conducted to assess the clinical outcomes of inhaled amikacin in VAP treatment. 180 ventilated patients with VAP were recruited from the two Intensive Care Units of Lahore General Hospital Surgical between January to December 2024. Patients were divided into two groups: one received empirical intravenous antibiotics (group N), and the other was administered inhaled amikacin along with empirical intravenous antibiotics (group A). Clinical variables including the duration of mechanical ventilation, length of stay in the ICU and symptom resolution, were compared between the two groups using t-tests and chi-square tests.
Results: Group A had a statistically significant shorter mean duration of mechanical ventilation than patients in Group N (6.8 days vs. 9.36 days, p<0.05). However, there was no significant difference in the mean duration of ICU stay between the two groups (13.9 days vs. 14.3 days, p=0.290). Group A had a higher percentage of symptom resolution compared to Group N (88% vs. 57%,…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 180 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.